Literature DB >> 33129135

A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons.

Rita Komalasari1, Sarah Wilson2, Sally Haw3.   

Abstract

BACKGROUND: Opioid Agonist Treatment (OAT) programmes are regarded as a gold standard treatment for people living with Opioid Use Disorders (OUDs). However, OAT programmes are often unavailable or poorly implemented in prisons, in spite of the large numbers of people living with OUDs and the high risk of HIV transmission in prison settings. Unusually, this systematic review synthesizes qualitative evidence relating to barriers to, and facilitators of, the implementation of OAT programmes in prisons in high- and low/middle-income countries (LMICs) to provide more nuanced, contextualised understandings of how prison stakeholders perceive and/or experience OAT programmes within different prison settings.
METHODS: We systematically reviewed six electronic databases for studies published between January 2005 and December 2019 involving prison stakeholders: policy-makers, governors, healthcare staff, prison officers, and prisoners. The search identified 8091 studies, of which only 16 incorporated qualitative methods (including qualitative elements of mixed methods) and met our quality criteria. Four of these studies were conducted in LMICs (Kyrgyzstan, Iran (2) and Indonesia).
RESULTS: Findings were organized under three broad themes: (1) perceived benefits of OAT programmes; (2) barriers to the implementation and development of OAT programmes; and (3) treatment processes. DISCUSSION: A lack of a clear understanding of the roles of OAT programmes and doubts regarding their effectiveness for people living with OUDs in prisons are critical barriers to prisoner participation in both high-and LMIC countries. Prison systems, particularly in LMICs, often lack the resources to mitigate problems with implementation. This review highlights an urgent need to develop further qualitative studies into prison OAT programmes, employing varied methods to explore such contexts in greater depth and minimize the impact of harms relating to OUDs in prisons.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Methadone; Opioid; Prison; Qualitative studies; Systematic review

Year:  2020        PMID: 33129135     DOI: 10.1016/j.drugpo.2020.102978

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  6 in total

1.  Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives.

Authors:  Ekaterina Pivovarova; Elizabeth A Evans; Thomas J Stopka; Claudia Santelices; Warren J Ferguson; Peter D Friedmann
Journal:  Drug Alcohol Depend       Date:  2022-03-07       Impact factor: 4.852

2.  Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.

Authors:  Cayley Russell; Frishta Nafeh; Michelle Pang; Shanna Farrell MacDonald; Dena Derkzen; Jürgen Rehm; Benedikt Fischer
Journal:  BMC Public Health       Date:  2022-03-04       Impact factor: 3.295

3.  Defining the Pre-exposure Prophylaxis Care Continuum Among Recently Incarcerated Men at High Risk for HIV Infection: Protocol for a Prospective Cohort Study.

Authors:  Matthew Murphy; Collette Sosnowy; Brooke Rogers; Siena Napoleon; Drew Galipeau; Ty Scott; Jun Tao; Justin Berk; Jennifer Clarke; Amy Nunn; Philip A Chan
Journal:  JMIR Res Protoc       Date:  2022-02-10

4.  Predicting Violent Reoffending in Individuals Released From Prison in a Lower-Middle-Income Country: A Validation of OxRec in Tajikistan.

Authors:  Gabrielle Beaudry; Rongqin Yu; Arash Alaei; Kamiar Alaei; Seena Fazel
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

Review 5.  A Qualitative Systematic Review of Access to Substance Use Disorder Care in the United States Criminal Justice System.

Authors:  Rachel E Barenie; Alina Cernasev; Hilary Jasmin; Phillip Knight; Marie Chisholm-Burns
Journal:  Int J Environ Res Public Health       Date:  2022-10-03       Impact factor: 4.614

Review 6.  The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy.

Authors:  Ali Cheetham; Louisa Picco; Anthony Barnett; Dan I Lubman; Suzanne Nielsen
Journal:  Subst Abuse Rehabil       Date:  2022-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.